BioMarker Strategies | GenomeWeb

BioMarker Strategies

The company has received grant funding for diagnostic development projects, and is also seeking its first pharma service customers to provide nearer-term revenue.

The funding will go towards developing the PathMap companion diagnostic technology, based on the firm's SnapPath platform. 

BioMarker Strategies has appointed Jerry Parrott as its new president, CEO, and director, effective immediately.

NEW YORK (GenomeWeb News) – BioMarker Strategies today announced it is being granted a $1.5 million Small Business Innovation Research Phase II award to further develop its companion diagnostic for melanoma.

Sera Prognostics has named Ilia Ichetovkin vice president of lab operations where he will head development and deployment of the company's CLIA lab services and the commercial launch of its proteomic test to predict preterm birth risk.

Third Rock Ventures has hired Felix Frueh as an entrepreneur-in-residence.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Tissue-based cancer diagnostics shop BioMarker Strategies has raised $1.1 million of a targeted $4 million round, a company executive confirmed.

Pairings

Premium

Kevin King, Frank Witney, Douglas Clark, Glen Miller

Pairings

Premium

William Welch, Dean Schorno, Samuel Broder, Mark Velleca, Paul Beresford, Leroy Hood

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.